JP2003519179A5 - - Google Patents

Download PDF

Info

Publication number
JP2003519179A5
JP2003519179A5 JP2001549648A JP2001549648A JP2003519179A5 JP 2003519179 A5 JP2003519179 A5 JP 2003519179A5 JP 2001549648 A JP2001549648 A JP 2001549648A JP 2001549648 A JP2001549648 A JP 2001549648A JP 2003519179 A5 JP2003519179 A5 JP 2003519179A5
Authority
JP
Japan
Prior art keywords
pregnane
unit dose
per unit
effective amount
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001549648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519179A (ja
Filing date
Publication date
Priority claimed from US09/475,328 external-priority patent/US6555531B1/en
Application filed filed Critical
Publication of JP2003519179A publication Critical patent/JP2003519179A/ja
Publication of JP2003519179A5 publication Critical patent/JP2003519179A5/ja
Pending legal-status Critical Current

Links

JP2001549648A 1999-12-30 2000-12-28 体重促進組成物、方法、および製品 Pending JP2003519179A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/475,328 1999-12-30
US09/475,328 US6555531B1 (en) 1999-12-30 1999-12-30 Weight promoting composition, method, and product
PCT/US2000/035573 WO2001049280A2 (en) 1999-12-30 2000-12-28 Weight promoting composition, method, and product

Publications (2)

Publication Number Publication Date
JP2003519179A JP2003519179A (ja) 2003-06-17
JP2003519179A5 true JP2003519179A5 (enExample) 2008-02-28

Family

ID=23887094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001549648A Pending JP2003519179A (ja) 1999-12-30 2000-12-28 体重促進組成物、方法、および製品

Country Status (11)

Country Link
US (1) US6555531B1 (enExample)
EP (1) EP1244458B1 (enExample)
JP (1) JP2003519179A (enExample)
AR (1) AR027136A1 (enExample)
AT (1) ATE374613T1 (enExample)
AU (1) AU2463301A (enExample)
CA (1) CA2394079C (enExample)
DE (1) DE60036640T2 (enExample)
ES (1) ES2292495T3 (enExample)
MX (1) MXPA02006568A (enExample)
WO (1) WO2001049280A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2008434A3 (cs) * 2008-07-10 2009-12-09 Ústav organické chemie a biochemie Akademie ved CR, v. v. i. Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917831A (en) * 1972-03-20 1975-11-04 Richardson Merrell Inc 3-Keto-7 {60 ,{62 -loweralkyl-{66 {0 5-steroids
US3946052A (en) * 1975-06-16 1976-03-23 Stanford Research Institute 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
BE1010266A4 (nl) 1996-04-15 1998-04-07 Option International Aanpassingseenheid voor datatransmissie tussen een mobiele telefoon en een gegevensterminal.
PL331357A1 (en) 1996-07-23 1999-07-05 Pherin Pharmaceuticals Steroids as neurochemical vno stimulators for soothing the symptoms of premenstrual tension and anxiety

Similar Documents

Publication Publication Date Title
US20250195470A1 (en) Formulations comprising triptan compounds
AU777827B2 (en) Aerosol formulations and devices for increasing libido in women via acute testosterone administration
US7226910B2 (en) Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists
JP2007527869A (ja) 両親媒性分子を懸濁ビヒクルとして含んでなる組成物および投薬形態
JP2005503374A (ja) 女性の性的欲求および性的反応性を高めるためのアンドロゲン作用薬の随時投与
JP2022088592A (ja) アルコール使用障害の処置のための組成物、装置、及び、方法
JPH08508280A (ja) 黄体ホルモン様作用薬を含む鼻用薬剤組成物
JP2005508963A (ja) 喘息を治療するためのサルメテロールとフルチカゾンプロピオネートを含む医薬の組み合せ
AU2002334126A1 (en) Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma
CN116549389A (zh) 鼻内肾上腺素制剂及治疗疾病的方法
JP2006504666A (ja) デヒドロエピアンドロステロン・ステロイド及び抗ムスカリン薬で呼吸器及び肺の疾患を治療するための組成物、配合物及びキット
CA2313618C (en) Transmucosal formulations of levosimendan
US6632419B2 (en) Increasing libido in humans via acute testosterone administration
Prajapati et al. The review on the nasal drug delivery
JP2003519179A5 (enExample)
TW200904452A (en) New drospirenone/17β-estradiol regimen, pharmaceutical combination, product and kit for performing this regimen
CN102933198A (zh) 包含曲普坦化合物的制剂
RU2234920C2 (ru) Введение непероральным путем андрогенных стероидов женщинам
EP1957121B1 (en) Acute treatment of social phobia with an androsta-4,16-dien-3-ol steroid
JPH09510697A (ja) 14α,17α−エタノエストラ−1,3,5(10)−トリエン−3,17β−ジオールを含有する経皮投与のための薬剤
JPS60214730A (ja) 軟膏基剤
Dugger III et al. Immediate-Immediate Release (I2R) Lingual or Buccal Spray Formulations for Transmucosal Delivery of Drug Substances
JP2003519179A (ja) 体重促進組成物、方法、および製品
EP1175204A1 (en) Aerosol formulations and devices for increasing libido in women via acute testosterone administration